Resources
Presentations
Preemptively managing the side effects of cancer treatment through model-driven clinical decision support: A case study.
Presented By
Michael Carey Scalzo, MPHDirector, Dana-Farber Pathways
Description
Cancer treatment has side effects. Regardless of their diagnosis, all cancer patients have the potential to experience a wide range of symptoms related to therapy or the progression of their disease. Given that the current approach to symptom management is often fragmented and reactive, Dana-Farber Cancer Institute has launched an innovative initiative to preemptively managed the side effects of cancer therapy by leveraging digital technologies. Central to this effort is Dana-Farber's partnership with Trisotech to integrate clinical decision support automation into providers' existing Epic EHR workflows.
Learn how it works
Request DemoConfirm your budget
Request PricingDiscuss your project
Request Meeting
We would like to use third party cookies to improve the functionality of this website.